Residual, Progressive or Recurrent Grade II or III Meningioma NEO100-02
Study details
View study details on clinicaltrials.gov.
Locations
- San Francisco
- Palo Alto
- Roseville
Clinical trial FAQs
Information for patients and study volunteers, including frequently asked questions.




